Drugs / WIN-901X
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01820481 | Sep 2012 → Nov 2013 | asthma | Whanin Pharmaceutical Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WIN-901X | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01820481 ↗ |
| Route | Oral | “100mg Bid, PO, 12weeks” NCT01820481 ↗ |